BRIEF published on 07/29/2024 at 14:05, 3 months 23 days ago Spetz Inc. Reports Financial Results for First Half of 2024 Financial Results EBITDA Revenue Net Loss Expenses
PRESS RELEASE published on 07/29/2024 at 14:00, 3 months 23 days ago Spetz Announces Results for the Three and Six Months Ended June 30 2024 Spetz Inc. reports financial results for Q2 2024, showing decreased expenses and losses. Strategic shift towards Israeli market contributes to revenue generation and efficiency improvements Financial Results Revenue Spetz Inc. Efficiency Israeli Market
BRIEF published on 06/10/2024 at 14:05, 5 months 11 days ago Spetz Enhances Cash Flow with Convertible Debenture and Warrant Offering Warrants Cash Flow Convertible Debentures Spetz Inc. Financial Strategy
PRESS RELEASE published on 06/10/2024 at 14:00, 5 months 11 days ago Spetz Enhances Cash Flow with Convertible Debenture and Warrant Offering Spetz Inc. announces debt conversion plan to improve cash flow. Selected vendors can convert outstanding payments into debentures and warrants, strengthening financial position Financial Position Cash Flow Spetz Inc. Debentures Debt Conversion Plan
BRIEF published on 05/15/2024 at 14:05, 6 months 6 days ago Spetz Inc. Reports Financial Outcomes for First Quarter of 2024 Revenue Growth Corporate Strategy EBITDA Improvement Net Loss Reduction Quarterly Financials
PRESS RELEASE published on 05/15/2024 at 14:00, 6 months 6 days ago Spetz Announces Results for the Three Months Ended March 31, 2024 Spetz Inc. reports financial results for Q1 2024, showing revenue growth of 4.6% and a decrease of 60% in net loss. The company emphasizes efficiency and profitability measures Financial Results Revenue Growth Spetz Inc. Efficiency Measures Net Loss Decrease
BRIEF published on 04/29/2024 at 14:05, 6 months 22 days ago Spetz Inc. Reports Doubling of Revenue in 2023 Financial Results Financial Results Revenue Growth Spetz Inc. Corporate Strategy EBITDA Improvement
PRESS RELEASE published on 04/29/2024 at 14:00, 6 months 22 days ago Spetz Announces Results for the Year Ended December 31, 2023 Spetz Inc. reported a 103.7% increase in revenue and a 17.0% decrease in adjusted EBITDA loss for FY 2023. CEO Nevo highlights strategic adjustments driving financial stability Financial Results Revenue Increase Spetz Inc. Adjusted EBITDA Loss Strategic Adjustments
BRIEF published on 04/08/2024 at 22:35, 7 months 12 days ago Spetz Inc. Implements Debt Conversion Plan to Strengthen Cash Flow Share Conversion Financial Strategy Cash Flow Enhancement Spetz Inc Debt Conversion
PRESS RELEASE published on 04/08/2024 at 22:30, 7 months 12 days ago Spetz Enhances Cash Flow with Debt Conversion Plan Spetz Inc. announces cash flow improvement through debt conversion plan, allowing vendors to convert outstanding payments into common shares, enhancing financial position and flexibility Common Shares Spetz Inc. Financial Flexibility Cash Flow Improvement Debt Conversion Plan
Published on 11/21/2024 at 14:15, 21 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 36 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 36 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 36 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 20 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 21 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 2 hours 1 minute ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 38 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 16 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 51 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 51 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
